117 related articles for article (PubMed ID: 19783381)
21. Post-marketing drug surveillance--how far have we got?
McDevitt D; MacDonald TM
Q J Med; 1991 Jan; 78(285):1-3. PubMed ID: 1670059
[No Abstract] [Full Text] [Related]
22. [Prevention of narcotic dependence in Polish legal regulations].
Morawska J
Przegl Lek; 1997; 54(6):452-5. PubMed ID: 9333900
[TBL] [Abstract][Full Text] [Related]
23. [Drug dependence syndrome as a side effect of medical drug use].
Ozaki S
Nihon Rinsho; 2007 Oct; 65 Suppl 8():357-61. PubMed ID: 18074563
[No Abstract] [Full Text] [Related]
24. [The latest tendency of uncontrolled substance inquiries to JPIC].
Kuroki Y
Chudoku Kenkyu; 2004 Jul; 17(3):241-3. PubMed ID: 15495682
[No Abstract] [Full Text] [Related]
25. Prescribing Schedule 8 drugs.
Bird S
Aust Fam Physician; 2006; 35(1-2):59-60. PubMed ID: 16489388
[TBL] [Abstract][Full Text] [Related]
26. Effectiveness of risk management plans: a case study of pemoline using pharmacy claims data.
Morrato EH; Staffa JA
Pharmacoepidemiol Drug Saf; 2007 Jan; 16(1):104-12. PubMed ID: 16821248
[TBL] [Abstract][Full Text] [Related]
27. Post-marketing experience with an opioid nasal spray for migraine: lessons for the future.
Loder E
Cephalalgia; 2006 Feb; 26(2):89-97. PubMed ID: 16426261
[TBL] [Abstract][Full Text] [Related]
28. WHO's programme in drug dependence with special emphasis on developing countries.
Khan I; Arif AE; Hughes PH; Cox B
NIDA Res Monogr; 1978; (19):41-50. PubMed ID: 106299
[No Abstract] [Full Text] [Related]
29. [Gammahydroxybutyrate must remain available for patients with narcolepsy].
Lammers GJ; van Dijk JG; Ferrari MD; van Gerven JM; Declerck AC; Troost J
Ned Tijdschr Geneeskd; 1999 Oct; 143(41):2062-3. PubMed ID: 10560549
[TBL] [Abstract][Full Text] [Related]
30. [Current topics on regulation of dependence-inducing drugs].
Yamamoto H
Nihon Shinkei Seishin Yakurigaku Zasshi; 1999 Oct; 19(4):199. PubMed ID: 10637827
[No Abstract] [Full Text] [Related]
31. Tackling Subutex abuse in Singapore.
Lee CE
Singapore Med J; 2006 Nov; 47(11):919-21. PubMed ID: 17075655
[No Abstract] [Full Text] [Related]
32. ED managers: head off drug seekers and the multiple risks they can pose.
ED Manag; 1996 May; 8(5):49-53. PubMed ID: 10172612
[No Abstract] [Full Text] [Related]
33. Misuse of psychotropic substances: outline and recommendations of a conference held in London in March 1980.
Ghodse AH; Khan I
Bull Narc; 1982; 34(3-4):83-90. PubMed ID: 6926514
[TBL] [Abstract][Full Text] [Related]
34. Post-marketing surveillance and adverse drug reactions.
Shani S
Isr Med Assoc J; 1999 Oct; 1(2):117-9. PubMed ID: 10731310
[No Abstract] [Full Text] [Related]
35. [Legal and illegal drugs--status, selected problems, trends].
Katzung W
Z Arztl Fortbild (Jena); 1992 Jul; 86(14):689-99. PubMed ID: 1529620
[No Abstract] [Full Text] [Related]
36. Screening workers for drugs: a legal and ethical framework.
Rothstein MA
Employee Relat Law J; 1985-1986 Winter; 11(3):422-37. PubMed ID: 10317703
[No Abstract] [Full Text] [Related]
37. Drugs and the social body.
Mann PS
Mt Sinai J Med; 1991 Oct; 58(5):427-32; discussion 437-42. PubMed ID: 1753982
[No Abstract] [Full Text] [Related]
38. Post-marketing surveillance of licensed medicinal and other products.
Griffin JP
Health Trends; 1981 Aug; 13(3):85-8. PubMed ID: 10258571
[TBL] [Abstract][Full Text] [Related]
39. The development of a comprehensive risk-management program for prescription opioid analgesics: researched abuse, diversion and addiction-related surveillance (RADARS).
Cicero TJ; Dart RC; Inciardi JA; Woody GE; Schnoll S; Muñoz A
Pain Med; 2007 Mar; 8(2):157-70. PubMed ID: 17305687
[TBL] [Abstract][Full Text] [Related]
40. [Drug dependence and drug abuse in the light of publications of the International Organ of Narcotic Control 1984-1986].
Kubalski J; Kotlarska M; Müller B
Pol Tyg Lek; 1988 May; 43(20):645-8. PubMed ID: 3217274
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
